ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO0727

Demographic and Clinical Characteristics of Patients with CKD and SARS-CoV2 Undergoing Hemodialysis Treatment

Session Information

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)

Authors

  • Fuentes-Mendez, Laura C, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
  • Cordoba Hurtado, Angela Maria, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
  • Perez-Navarro, L. Monserrat, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
  • Valdez-Ortiz, Rafael, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
  • Merino, Maribel, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
Background

Patients on HD or PD are likely to be at increased risk of COVID-19 and its complications because they have multiple comorbid conditions. There is a lack of evidence about the optimal management and even clinical manifestations because clinical presentation is highly variable. The delayed diagnosis is because it's not recognized by the treating centers and the confusion with patients with fluid overload or uremic syndrome can be fatal in this population.

Methods

Retrospective, observational, single-center study in Mexico. We analyzed the clinical manifestations and outcomes of all maintenance HD patients hospitalized with COVID-19 from April 9th to May 31st, 2020 as confirmed by real-time polymerase chain reaction

Results

20 patients followed in our hospital with median age of 45.2±13.8 years, 50% were men. All the patients have HTA (100%), DM (50%), the most common symptoms at admission were asthenia (75%), dyspnea (65%), cough (55%) followed by myalgias (50%) and fever (45%). Poor oxygen saturation (<95%) breathing room air was observed in 18 patients (90%) with mean oxygen saturation of 77± 9% . Lung abnormalities on initial chest X-ray were observed in all patients. Peripheral ground-glassopacities, the typical radiologic pattern, were bilateral in 13 patients and unilateral in 7. Laboratory studies with lymphopenia in 85% of patients with a mean of 0.7+0.38. There were no differences baseline leukocyte or lymphocyte from patients who survived vs from those who died. The mortality rate (40%) was much higher than that observed in the general population (8%). Mortality was higher in women.

Conclusion

The impact of this virus on patients with CKD is poorly understood. The evaluation of the nephrologist must be very detailed, most of the patients had mild dyspnea, however on physical examination, desaturation and radiological images were suggestive of infection by SARS-CoV2. The current situation provides a unique opportunity to gather vital information to process and learn from the experience worldwide. These results will allow us to treat them in a timely manner and reduce lethality in dialysis patients.